Temporary Extension Of COVID-19 Telemedicine Flexibilities For Prescription Of Controlled Medications
On May 10, 2023, the U.S. Department of Health and Human Services (HHS) published this temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. This temporary rule extendd certain exceptions granted to existing DEA regulations in March 2020 as a result of the COVID-19 Public Health Emergency (COVID-19 PHE), to avoid lapses in care for consumers . . .